Cite Filings / VRTX / 0000875320-26-000153
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
DEF 14A

Proxy Statement

VERTEX PHARMACEUTICALS INC / MA · Filed 2026-04-02 · Acc 0000875320-26-000153

Documents 1

  • DEF 14A Proxy Statement , vrtx-20260402.htm

Around this filing

  • 2026-04-03 4 EVP and Chief Legal Officer sold 978 shares at $449.17 ($439,288)
  • 2026-04-02 ARS Annual Report to Security Holders
  • 2026-04-02 DEFA14A Proxy Materials
  • 2026-04-02 DEF 14A Proxy Statement
  • 2026-04-01 144 Sale of Securities
  • 2026-04-01 CORRESP Correspondence Between Filers and SEC Staff
  • 2025-04-03 DEF 14A Proxy Statement

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading vrtx-20260402.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…